JPRN-UMIN000045727尚未招募未知
A randomized, open-label, parallel-group study to evaluate the efficacy of dry chemical mopping in adults with mild to moderate atopic dermatitis. - Cleaning Research
Mie University, Graduate School of Medicine0 个研究点目标入组 42 人开始时间: 2021年10月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Persons who are active during the night and sleep during the day 2) Persons who are judged by the principal investigator or sub-investigator to be inappropriate as research subjects.
研究者
相似试验
进行中(未招募)
不适用
A randomized, open-label, parallel-group study to investigate blood concentrations, safety and tolerability of 2 ointment formulations of ASM981 in adult patients with atopic dermatitis treated topically for 2 weeks - A2308Atopic dermatitis (atopic eczema)EUCTR2004-003798-94-ATovartis Pharma Services AG20
尚未招募
3 期
The Study to evaluate the effectiveness of Abrocitinib Tablets in People With Atopic Dermatitis in IndiaCTRI/2022/06/043406Pfizer Inc
招募中
1 期
To evluate the safety profile of NR-INF-02CTRI/2018/02/011766atrural Remedies Private Limited
已完成
不适用
A randomized, open-label, parallel group study to evaluate the efficacy and safety of the oral administration of Bifidobacterium animalis subsp. lactis LKM512 in patients with atopic dermatitisAtopic dermatitisJPRN-UMIN000005695Kyodo Milk Industry Co. Ltd.50
进行中(未招募)
3 期
An Open-Label, Randomized, Parallel-Group Study of Bendamustine Hydrochloride and Rituximab (BR) Compared with Rituximab, Cyclophosphamide, Vincristine, and Prednisone (R-CVP) or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in the First-Line Treatment of Patients with Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL).on-Hodgkin's LymphomaNon-Hodgkin's LymphomaCancer - Lymphoma (non Hodgkin's lymphoma) - Low grade lymphomaCancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphomaACTRN12610000445077Cephalon Inc436
